ENANTA PHARMACEUTICALS, INC Unrecognized Tax Benefits, Period Increase (Decrease)
ENANTA PHARMACEUTICALS, INC (ENTA) reported Unrecognized Tax Benefits, Period Increase (Decrease) of $539.00 thousand for the 9-month period ending 2020-06-30, per its 10-Q filed 2020-08-10.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease · last filed 2020-08-10
- ENANTA PHARMACEUTICALS, INC unrecognized tax benefits, period increase (decrease) for the quarter ending 2020-03-31 was $539.00K.
| Period end | Unrecognized Tax Benefits, Period Increase (Decrease) 3 month | Unrecognized Tax Benefits, Period Increase (Decrease) 9 month |
|---|---|---|
| 2020-06-30 | $539.00K 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $539.00K 10-Q · filed 2020-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |